Equities

Nipro Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Nipro Corp

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,536.50
  • Today's Change-23.50 / -1.51%
  • Shares traded653.90k
  • 1 Year change+17.07%
  • Beta0.3815
Data delayed at least 15 minutes, as of Feb 20 2026 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nipro Corp is a Japan-based company mainly engaged in the medical, pharmaceutical, and pharma packaging businesses. It has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.

  • Revenue in JPY (TTM)652.61bn
  • Net income in JPY15.20bn
  • Incorporated1948
  • Employees39.17k
  • Location
    Nipro Corp3-26, Senriokashin-machiSETTSU-SHI 566-8510JapanJPN
  • Phone+81 663106804
  • Fax+81 663717422
  • Websitehttps://www.nipro.co.jp
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
8086:TYO since
announced
Transaction
value
G2/Spryte Holdco LLCAnnounced28 Oct 202528 Oct 2025Announced-1.41%--
Data delayed at least 15 minutes, as of Feb 20 2026 06:30 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PHC Holdings Corp363.93bn3.54bn135.97bn9.04k39.120.85224.510.373627.4327.432,861.021,259.090.66233.405.2440,253,730.000.60380.1061.120.161745.2546.910.91170.17380.36061.640.6084916.512.175.81181.3214.73-1.83--
Menicon Co Ltd123.91bn6.85bn143.70bn4.33k20.561.488.581.1691.0791.071,629.401,267.140.61232.528.5528,650,640.003.394.124.195.1453.6753.025.545.611.86--0.442129.354.567.5323.876.7221.9814.87
Hogy Medical Co Ltd37.84bn222.00m150.99bn1.41k648.241.9426.663.9910.3410.341,754.863,454.270.39192.752.8726,856,640.000.22993.510.25233.8632.3037.880.58679.384.1460.780.140454.660.09721.00-45.79-22.76-12.153.92
As One Corp107.58bn8.97bn167.77bn731.0017.792.3215.541.56125.12125.121,500.44959.871.126.053.11147,174,000.009.387.8112.6210.7230.4230.598.348.062.24--0.072751.928.608.079.726.64-16.129.16
Mani Inc30.14bn4.94bn172.81bn4.14k32.202.9123.195.7350.1650.16305.99555.200.51561.6110.587,280,435.008.4510.449.0711.1964.6163.2116.4021.956.27--0.001261.755.1014.54-26.146.8831.5612.13
Nakanishi Inc81.18bn-2.40bn235.16bn2.18k--1.8668.932.90-29.41-29.41969.191,373.650.50981.398.47---1.518.35-1.849.7356.7459.43-2.9516.562.57--0.190138.605.3719.69-127.96--34.8412.47
Ship Healthcare Holdings Inc708.37bn13.99bn256.21bn7.81k18.131.6912.210.3617149.82149.827,579.631,609.071.8518.395.1990,758,740.003.573.657.207.009.4110.411.932.251.16--0.15633.317.496.969.715.091.879.11
Nipro Corp652.61bn15.20bn267.48bn39.17k19.130.99733.270.409981.5681.563,649.421,564.270.55641.793.9316,661,790.001.451.112.371.7130.1029.842.612.010.7634.880.675242.899.857.81-53.97--5.7413.12
Nihon Kohden Corp230.96bn12.37bn286.87bn6.11k22.171.5816.081.2475.6975.691,415.011,062.470.93691.813.8837,775,760.005.048.436.5411.0851.8851.545.388.492.31--0.12928.591.554.03-17.207.4319.3912.12
Fukuda Denshi Co Ltd138.47bn17.96bn353.31bn3.47k14.571.4112.012.55642.29642.294,964.156,648.580.6513.954.0939,962,190.008.448.579.8010.6354.0050.2812.9712.343.32--0.009829.45-0.93780.8279-0.470814.13-0.247916.80
Data as of Feb 20 2026. Currency figures normalised to Nipro Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

18.71%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Feb 20265.42m3.16%
Nomura Asset Management Co., Ltd.as of 08 Jan 20265.24m3.05%
American Century Investment Management, Inc.as of 05 Feb 20263.81m2.22%
Dimensional Fund Advisors LPas of 05 Feb 20263.59m2.09%
Norges Bank Investment Managementas of 30 Jun 20253.06m1.78%
Asset Management One Co., Ltd.as of 14 Nov 20252.96m1.73%
Amova Asset Management Co., Ltd.as of 06 Feb 20262.48m1.45%
Daiwa Asset Management Co. Ltd.as of 30 Jan 20262.31m1.35%
BlackRock Fund Advisorsas of 06 Feb 20262.15m1.25%
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Feb 20261.07m0.62%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.